| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.04 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |